Treatment outcomes and unfavorable prognostic factors in patients with occult breast cancer

被引:62
作者
He, M. [1 ,2 ]
Tang, L. -C. [1 ,2 ]
Yu, K. -D. [1 ,2 ]
Cao, A. -Y. [1 ,2 ]
Shen, Z. -Z. [1 ,2 ]
Shao, Z. -M. [1 ,2 ]
Di, G. -H. [1 ,2 ]
机构
[1] Fudan Univ, Ctr Canc, Inst Canc, Dept Breast Surg, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
来源
EJSO | 2012年 / 38卷 / 11期
关键词
Occult breast cancer; Clinical outcome; Prognostic factor; LYMPH-NODE METASTASES; CARCINOMA-IN-SITU; AXILLARY METASTASES; UNKNOWN PRIMARY; EXPERIENCE; MANAGEMENT; LYMPHADENOPATHY; BIOPSY; TUMORS;
D O I
10.1016/j.ejso.2012.08.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: The purpose of this study was to evaluate the treatment outcomes and prognostic factors in patients with occult breast cancer (OBC). Methods: We retrospectively analyzed 95 patients with OBC who were treated at our facility between January 1998 and June 2010. Of the 95 patients, 64 underwent mastectomy plus axillary lymph node dissection (ALND) with or without post-mastectomy radiation (Mast + ALND group), 13 underwent ALND followed by ipsilateral breast radiotherapy (BR + ALND group) and the remaining 18 were treated with ALND (ALND group). Results: Patients who underwent Mast + ALND or BR + ALND had significantly improved rates of locoregional recurrence-free survival (LRFS) and recurrence/metastasis-free survival (RFS) than patients who only underwent ALND (p < 0.05). There were no significant differences in the LRFS (p = 0.718), RFS (p = 0.935) and breast cancer-specific survival (BCSS) (p = 0.991) rates between the patients who underwent Mast + ALND compared with those who received BR + ALND. Multivariate analysis revealed that patients with four or more involved lymph nodes had significantly worse outcomes (p = 0.042, HR = 4.63, 95% CI = 1.66-32.47 for BCSS and p = 0.038, HR = 3.62, 95% CI = 1.08-20.77 for RFS). Conclusions: Patients with OBC who received ALND and subsequent breast radiotherapy had similar outcomes to patients who underwent mastectomy. The presence of four or more involved lymph nodes may independently predict poor outcomes of OBC. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1022 / 1028
页数:7
相关论文
共 33 条
[1]   ANALYSIS OF A DIAGNOSTIC STRATEGY FOR PATIENTS WITH SUSPECTED TUMORS OF UNKNOWN ORIGIN [J].
ABBRUZZESE, JL ;
ABBRUZZESE, MC ;
LENZI, R ;
HESS, KR ;
RABER, MN .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :2094-2103
[2]   UNKNOWN PRIMARY-CARCINOMA - NATURAL-HISTORY AND PROGNOSTIC FACTORS IN 657 CONSECUTIVE PATIENTS [J].
ABBRUZZESE, JL ;
ABBRUZZESE, MC ;
HESS, KR ;
RABER, MN ;
LENZI, R ;
FROST, P .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) :1272-1280
[3]  
BARON PL, 1990, ARCH SURG-CHICAGO, V125, P210
[4]   The role of ipsilateral breast radiotherapy in management of occult primary breast cancer presenting as axillary lymphadenopathy [J].
Barton, Sarah R. ;
Smith, Ian E. ;
Kirby, Anna M. ;
Ashley, Sue ;
Walsh, Geraldine ;
Parton, Marina .
EUROPEAN JOURNAL OF CANCER, 2011, 47 (14) :2099-2106
[5]   Retrospective study of women presenting with axillary metastases from occult breast carcinoma [J].
Blanchard, DK ;
Farley, DR .
WORLD JOURNAL OF SURGERY, 2004, 28 (06) :535-539
[6]   Utility of breast magnetic resonance imaging in patients with occult primary breast cancer [J].
Buchanan, CL ;
Morris, EA ;
Dorn, PL ;
Borgen, PI ;
Van Zee, KJ .
ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (12) :1045-1053
[7]   PRESENTATION OF AXILLARY LYMPHADENOPATHY WITHOUT DETECTABLE BREAST PRIMARY (T0 N1B BREAST-CANCER) - EXPERIENCE AT INSTITUT-CURIE [J].
CAMPANA, F ;
FOURQUET, A ;
ASHBY, MA ;
SASTRE, X ;
JULLIEN, D ;
SCHLIENGER, P ;
LABIB, A ;
VILCOQ, JR .
RADIOTHERAPY AND ONCOLOGY, 1989, 15 (04) :321-325
[8]   Clinical experience with axillary presentation breast cancer [J].
Galimberti, V ;
Bassani, G ;
Monti, S ;
Simsek, S ;
Villa, G ;
Renne, G ;
Luini, A .
BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 (01) :43-47
[9]   Progress and promise:: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 [J].
Goldhirsch, A. ;
Wood, W. C. ;
Gelber, R. D. ;
Coates, A. S. ;
Thuerlimann, B. ;
Senn, H.-J. ;
Members, Panel .
ANNALS OF ONCOLOGY, 2007, 18 (07) :1133-1144
[10]  
Hainsworth JD, 2000, ONCOLOGY-NY, V14, P563